oxycodone and semaglutide Medscape | The FDA has approved once-daily oral 25 mg (Wegovy Pill, Novo Nordisk) as the first GLP-1 agonist pill for weight management. TrimRX | Navigating Medications: Can
Description
Unknown long-term safety
As patients and clinicians explore these medications' broader metabolic impacts, questions arise about potential effects on cortisolthe stress hormone linked to central weight gain and insulin resistance
This risk appears to increase with treatment duration beyond 1.5 years
But it is not a quick fix, and it is not FDA-approved by itself for weight loss
The answer is straightforward: if a medication is safe and effective for a condition, off-label prescription is standard medical practice
Between-individual variability was estimated to be 56% after a single dose as well as at steady state
